In HF with LVEF ≤ 42.5%, sacubitril-valsartan vs RAS inhibitors reduced a composite of CV death or HF hospitalization.
Journal Article
SOURCE CITATION: Solomon SD, Vaduganathan M, Claggett BL, et al. Sacubitril/valsartan across the spectrum of ejection fraction in heart failure. Circulation. 2020;141:352-61. 31736342.
Full Text
Duke Authors
Cited Authors
- Sen, S; Newby, LK
Published Date
- June 16, 2020
Published In
Volume / Issue
- 172 / 12
Start / End Page
- JC65 -
PubMed ID
- 32539517
Pubmed Central ID
- 32539517
Electronic International Standard Serial Number (EISSN)
- 1539-3704
Digital Object Identifier (DOI)
- 10.7326/ACPJ202006160-065
Language
- eng
Conference Location
- United States